Readily Diagnostics develops molecular tests that help clinicians identify infectious diseases near the patient without relying on a central laboratory.
GF
Gates Foundation
Activity from announced rounds
All recorded activity
- Rounds participated in
- 8
- Confirmed lead rounds
- 0 6 roles undisclosed
- New companies
- 8 First participation on record · 0 follow-on
- Funding in participating rounds
- $178.8M 6 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
8 in all activityReadily Diagnostics
~$970KGates Foundation grant
ParticipantProFound Therapeutics
Uses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia
$35MStrategic
Role not disclosedLeyden Laboratories
Develops antibody-based nasal sprays intended to prevent influenza and other respiratory-virus infections.
€40MSeries B
Role not disclosedKanvas Biosciences
Develops microbiome-based live biotherapeutics for cancer patients who do not respond to immunotherapy
$48MSeries A
Role not disclosedTen63 Therapeutics
Develops AI-driven drug discovery platform for first- and best-in-class therapeutics
$45MStrategic
Role not disclosedHeritable Agriculture
Develops AI-driven crop improvement solutions for climate-resilient crops
$5MGrant
Role not disclosedQure.ai
Develops AI-powered diagnostic solutions for early detection and care management of diseases
UndisclosedGrant
Role not disclosedHelium Health
Helium Health provides healthcare software, digital payment tools and financing services for African healthcare providers.
$499.9KMaternal health grant
Participant